The Basque Health Cluster is the association for the bioscience and health sector. Our main objective is to coordinate, represent, manage, promote and defend the common interests of our member companies.
Our lines of action
What is our differential value proposal?
As our primary goal is to contribute to people’s health and well-being, we are commited to the Sustainable Development Goals.
History
BioBasque Strategy
In 2000, the Basque Government advocated providing a boost to the Basque economy in order to adapt to an increasingly changing and competitive world, making a strategic commitment to new strategic sectors based on knowledge and innovation. This resulted in 2002 in the first strategy designed specifically for developin biosciences in Spain: the 2010 BioBasque Strategy.
Basque Biocluster
It was constituted on 17 October 2010 as the “Basque Biocluster” association, which was made up of 14 founding companies:
- AJL OPHTALMIC
- BIOFTALMIK
- BIOLAN MICROBIOSENSORES
- BIOTECHNOLOGY INSTITUTE (BTI)
- DOMINION PHARMAKINE
- HISTOCELL
- IDOKI SCF TECHNOLOGIES
- INKOA SISTEMAS
- INNOVATIVE TECHNOLOGIES IN BIOLOGICAL SYSTEMS (INNOPROT)
- LABORATORIUM SANITATIS (LABSAN)
- LABORATORIOS BROMATOLOGICOS ARABA
- NORAY BIOINFORMATICS
- ONE WAY LIVER GENOMICS (OWL GENOMICS)
- PROGENIKA BIOPHARMA
Basque Health Cluster
Years later, after a strategic review focusing on the sector’s market and identifying the health sector as the main niche activity of its members, the Board of Directors decided to broaden the cluster’s sphere of action. Consequently, in January 2017, the Basque Biocluster became the Basque Health Cluster. Healthcare delivery, medical devices and digital health would now become part of the cluster.
Tenth anniversary durign the SARS-CoV-2 pandemic: Celebrating 10 years of service
When the pandemic struck in 2020, it highlighted the importance of having a bio-health sector with productive capacity. The pandemic crisis highlighted the need to invest in the bio-health sector as an essential component. The cluster has managed the crisis by informing, coordinating and intervening to speed up urgent responses, in collaboration with public and private companies and institutions. The cluster, now in its tenth year, has become the backbone of the Basque bio-health ecosystem with a growing number of members.
In addition to a good health and social healthcare system and excellent healthcare professionals, it is essential to have industrial capacities for manufacturing medical devices and medicines.
In this context, the Basque Health Cluster will consolidate itself to become a cluster organisation of excellence, which efficiently and sustainably represents and promotes the development of the bioscience and health sector in the Basque Country and its international positioning.
Governance
Executive Committe
Asier Albizu
President
Biolan Health S. L.
Julio Font
Vicepresident
Histocell S. L.
María Eugenia Puertas
Treasurer
Oiarso S. Coop.
Arantza Muriana
Secretary
BioPhenix S.L.
Cluster management
Idoia Muñoz Lizán
Basque Health Cluster
The executive body of the Basque Health Cluster is the Board of Directors
Azucena Castro
Basque Trade & Investment
Iñaki Gutierrez Ibarluzea
Bioef
Asier Albizu
Biolan Health S. L.
Arantza Muriana
BioPhenix (Biobide)
Jorge Presa
Cyber-Surgery
Tatiana Suárez
Faes Farma
Carlos Fernández
Gogoa
Julio Font
Histocell
Clarisa Salado
Innoprot
Unai Atristain
Cardiva
Gaizka Grajales
Mizar
María Eugenia Puertas
Oiaso S. Coop
Pedro Esnaola
Oncomatryx
Manu Díaz de Corcuera
Quirón Salud
Iñigo Pagoaga
Roxall
Nerea Briz
Tecnalia Research & Innovation
Juan Basterra
Mikrobiomik
The sovereign body of the Basque Health Cluster association is the General Assembly, which is made up of all the members who attend the session called for this purpose.
Business Partner
Partners
